A new funding program to support biopharmaceutical manufacturing development
03 April, 2014The first round of a new pilot funding program opens this week in Queensland, with at least $2 million available for biopharmaceutical product developers wanting to make use of BioPharmaceuticals Australia's (BPA) new mammalian cell contract manufacturing facility, operated by DSM Biologics (DSMB).
Simon McKeon to give National Press Club Address
01 April, 2014AusBiotech has welcomed news that Simon McKeon AO will speak at the National Press Club in Canberra about the Strategic Review of Health and Medical Research in Australia.
Analytica close to US, EU filings for PeriCoach
01 April, 2014 by Dylan Bushell-EmblingAnalytica (ASX:ALT) will soon be ready to file EU CE Mark and US 510(k) submissions for PeriCoach, a device for treating female urinary incontinence that is already approved in Australia.
dorsaVi teams with insurer to promote OHS device
01 April, 2014 by Dylan Bushell-EmblingdorasVi (ASX:DVL) has entered a partnership with insurer Allianz to recommend the use of ViSafe - a device for measuring movement and muscle activity - for Australian labourers.
pSivida partner files fourth US NDA for Iluvien
31 March, 2014 by Dylan Bushell-EmblingpSivida (ASX:PVA) licensee Alimera Sciences has made its third resubmission of its US New Drug Application for diabetic macular edema treatment Iluvien.
GI Dynamics hits Netherlands reimbursement milestone
28 March, 2014 by Dylan Bushell-EmblingA Dutch hospital has won approval to be reimbursed for some procedures involving GI Dynamics' (ASX:GID) EndoBarrier so that healthcare authorities can evaluate allowing nationwide reimbursement.
Government releases statement on the Pharmaceutical Patents Review
27 March, 2014The federal government last week released a statement on the Pharmaceutical Patents Review report, confirming it "has no plans to respond to the report at this stage".
Cochlear's first-of-its-kind hybrid device gets regulatory approval in US
25 March, 2014After the US FDA approved the first-of-its-kind hearing device, Cochlear has launched a new hybrid hearing solution that helps people's hearing by amplifying low-frequency hearing and restoring access to high-frequency hearing, and will open up new opportunities in the US market.
Cochlear cleared to sell new device in US
21 March, 2014 by Dylan Bushell-EmblingThe FDA has granted Cochlear (ASX:COH) approval to sell the Nucleus Hybrid L24 - a new cochlear implant system designed to address high-frequency hearing loss - in the US.
AusMedtech 2014 business matching now open
20 March, 2014The AusMedtech 2014 conference has re-introduced AusPartnering, a business matching and partnering platform allowing delegates to schedule 30-minute one-on-one meetings with other attendees in a dedicated meeting area. All conference attendees have access to the AusPartnering system upon registration.
New reference guide to agbiotech launched in Canberra
18 March, 2014The Agricultural Biotechnology Council of Australia (ABCA) today launched 'The Official Australian Reference Guide to Agricultural Biotechnology and GM Crops' to provide factual information about genetically modified crops based on scientific evidence and to provide a useful reference.
Mesoblast's new appointments "increase global visibility"
13 March, 2014 by Dylan Bushell-EmblingMesoblast's (ASX:MSB) hiring of a former Novartis CFO so soon after former Roche executive William Burns joined its board may help the company pursue international partnership deals, Bell Potter said.
Save the date for 'beaches, brains and biotech' at AusBiotech 2014 on the Gold Coast
13 March, 2014Wednesday 29 to Friday 31 October are the dates to save as the AusBiotech 2014 national conference heads for the Gold Coast at the Gold Coast Convention & Exhibition Centre.
CNS expands into UK, biometrics
12 March, 2014 by Dylan Bushell-EmblingBrisbane-based CRO CNS has opened a new office in London and launched a new biometrics service for its biotech industry customers.
Helping entrepreneurial students and recent graduates tap in
11 March, 2014Students and recent graduates with ideas in micro-, nano-, biotechnology or medical devices can apply for a grant to access an advanced technology co-working space.
